USF-LVHN SELECT
CAMKV Is a Candidate Immunotherapeutic Target in
Publication/Presentation Date
1-1-2020
Abstract
We developed a computational pipeline designed to use RNA sequencing (
Volume
10
First Page
302
Last Page
302
ISSN
2234-943X
Published In/Presented At
Sussman, R. T., Rokita, J. L., Huang, K., Raman, P., Rathi, K. S., Martinez, D., Bosse, K. R., Lane, M., Hart, L. S., Bhatti, T., Pawel, B., & Maris, J. M. (2020). CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma. Frontiers in oncology, 10, 302. https://doi.org/10.3389/fonc.2020.00302
Disciplines
Medical Education | Medicine and Health Sciences
PubMedID
32211329
Department(s)
USF-LVHN SELECT Program, USF-LVHN SELECT Program Students
Document Type
Article
COinS